TRVI
#1847
Trevi Therapeutics, Inc. - Common Stock
17.2 4 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.01%
Monthly Change
-6.66%
6 month change
+46.72%
Year Change
+140.45%
Previous Close
17.9 6
Open
17.8 8
Low
17.1 4
High
18.0 9
Volume
303
Financials
- Market Capitalization 2.46 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1839 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 26.19 USD | -0.27% | -0.91% | +1.63% | -13.48% | 2.58 B USD | ||
| 1841 |  PGEN Precigen, Inc. - Common Stock | 7.10 USD | -1.25% | -0.42% | +27.70% | +57.08% | 2.54 B USD | ||
| 1849 |  NKTR Nektar Therapeutics - Common Stock | 72.88 USD | -2.24% | -2.59% | +2.37% | -0.53% | 2.49 B USD | ||
| 1854 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.88 USD | +0.10% | +0.61% | +2.28% | +16.78% | 2.52 B USD |
Frequently asked questions about Trevi Therapeutics, Inc. Common Stock
What is the Trevi Therapeutics, Inc. Common Stock stock price today?
The current price of Trevi Therapeutics, Inc. Common Stock (TRVI) is 17.24. Over the past 24 hours, the stock has changed by -4.01%. Follow the TRVI chart for real-time price dynamics.
What is the stock ticker of Trevi Therapeutics, Inc. Common Stock?
Trevi Therapeutics, Inc. Common Stock trades under the ticker TRVI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Trevi Therapeutics, Inc. Common Stock stock going up?
TRVI has changed by -5.27% over the last week, -6.66% over the last month, and +140.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Trevi Therapeutics, Inc. Common Stock?
Trevi Therapeutics, Inc. Common Stock currently has a market capitalization of 2.46 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Trevi Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Trevi Therapeutics, Inc. Common Stock reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Trevi Therapeutics, Inc. Common Stock revenue for the last quarter?
Trevi Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Trevi Therapeutics, Inc. Common Stock net income for the last quarter?
Trevi Therapeutics, Inc. Common Stock reported net income of -17.8 M for the last quarter. The previous quarter showed -13.19 M, which means net income changed by -34.91%.
How many employees does Trevi Therapeutics, Inc. Common Stock have?
As of the latest available data, Trevi Therapeutics, Inc. Common Stock has 34 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Trevi Therapeutics, Inc. Common Stock stock?
You can buy Trevi Therapeutics, Inc. Common Stock (TRVI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Trevi Therapeutics, Inc. Common Stock stock?
Investing in Trevi Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TRVI chart and related analysis on metatrader.com as part of your research.